Navigation Links
Pharmacovigilance: ADR Management and Reporting & Outsourcing Trends, A New Drug Safety Webinar from Xtalks
Date:11/22/2013

Toronto, Canada (PRWEB) November 22, 2013

Join Dr. Marcin Marciniak, Director Drug Safety & Pharmacovigilance, PregLem SA, and member of Gedeon Richter Group and Dr. Philip Jones, BMBS, MA, MSc, PhD, Associate Director & Deputy QPPV, Symogen Limited for an in depth webinar on Adverse Drug Reaction Management and Reporting and Pharmacovigilance Outsourcing Trends.

During this webinar, the following points will be discussed:

Adverse Drug Reaction Management and Reporting

  • Key Requirements
  • Timeliness for expedited reporting
  • Reporting to EudraVigilance
  • Tools and internal industry solutions for being compliant with regulations

Pharmacovigilance Outsourcing Trends

  • Benefits and challenges involved in outsourcing pharmacovigilance processes
  • Advantages and disadvantages of outsourcing
  • Choosing a pharmacovigilance provider
  • Working with your PV provider
*Ensuring oversight of out-sourced activities
  • Brief insights into the role of pharmacovigilance throughout the product lifecycle from clinical development to patient care
  • Presenting a PSUR to external regulatory authorities
  • Main pitfalls
  • Completing the risk-benefit analysis

A live Q&A with the audience will follow the main presentation.

For more information about this online seminar or to register, go to http://xtalks.com/xto676-pharmacovigilance-ADR-outsourcing.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutic
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
2. Mexican State of Tamaulipas Starts Training Doctors in Sangui Wound Management
3. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
4. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
5. GeNO LLC Makes Significant Additions to Management Team to Increase Capability and Talent
6. MarketsandMarkets: Global Clinical Trial Management Systems Market Worth $1300.4 Million by 2016
7. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
8. BioStorage Technologies to Host Global Sample Management Workshop at Partnerships in Clinical Trials
9. Medical Experts Who Participated in CSL Behrings Key Issues Dialogue Prefer Albumin for Fluid Management
10. Medstreaming Launches Web-Based Analytics for All in One EMR/PACS/Practice Management Platform at HIMSS
11. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... PARK, N.C., July 28, 2015  United Therapeutics Corporation ... results for the second quarter ended June 30, 2015. ... as compared to the second quarter of 2014 ... Jeffs, Ph.D., United Therapeutics, President and Co-Chief Executive ... to an increase in the number of patients ...
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, 2015 /PRNewswire/ ... health care services and one of the largest ... that its parent company and sole stockholder, Capella ... Medical Properties Trust, Inc. ("MPT") (NYSE: MPW ... cash.  The transaction is expected to be finalized ...
(Date:7/27/2015)... ... July 27, 2015 , ... Brady (NYSE:BRC), ... video: 3 Ways to GHS Labels . This video provides useful information ... System (GHS) by effectively labeling chemical containers. , “With the fourth and final ...
(Date:7/27/2015)... 2015 According to the new Market ... Pre-formulated Media), by Application (Biobanking, Regenerative Medicine, Drug Discovery), by ... , Asia-Pacific , Rest of the ... media market was valued at $247.7 million in 2014, which ... at a CAGR of 18.2% between 2014 and 2019. ...
Breaking Biology Technology:United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Brady Releases “3 Roads to GHS Labels” Video 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3
... , ... ... ... ...
... ... GIA announces the release of a comprehensive global ... reach $4.94 billion by the year 2015. Although temporarily tempered by ... the capital crunch is fairly short-lived. The market is expected to ...
... ... Day, hopes to bring more attention to the need for finding more treatments for diseases ... ... more attention to the urgent need of finding more treatments for rare diseases by partnering ...
Cached Biology Technology:Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 2Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 3Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 4Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 5Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 6Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 7Global Nanobiotechnology Market to Reach $4.94 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2Global Nanobiotechnology Market to Reach $4.94 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3Global Nanobiotechnology Market to Reach $4.94 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 4Raising Awareness of Rare Diseases, Anson Group Announces Sponsorship of Rare Disease Day 2
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... has been observed in rats who will free trapped ... but requires prior, positive social interactions with the type ... University of Chicago, in the open access journal ... suggest that social experiences, not genetics or kin selection, ...
... to biofuels, corn leads the all-important category of biomass yield. ... In the current issue of the Proceedings for ... show that looking at the big picture allows other biofuel ... viable alternatives. "We believe our findings have major implications ...
... , January 13, 2014 ... ) has announced the addition of the  ... to their offering.  ,     ... the use of bioinformatics, the various sectors ...
Cached Biology News:Social experience drives empathetic, pro-social behavior in rats 2Social experience drives empathetic, pro-social behavior in rats 3More to biofuel production than yield 2Global Bioinformatics Market 2013 - 2017 2Global Bioinformatics Market 2013 - 2017 3
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
...
RABBIT ANTI D-TYROSINE CONJUGATE...
... Spots and complementary RNA Spikes for the ... for glass array printing and for protocol ... cDNA labeling, hybridization stringency and background. Normalize ... Spots and Oligo Spots, and complementary RNA ...
Biology Products: